Pancreatic islet beta-cell (Beta-cell) (Beta-cell)

Pancreatic islet beta-cells are specialized endocrine cells located within the islets of Langerhans in the pancreas. Their primary biological function is the synthesis, storage, and release of insulin in response to elevated blood glucose levels, thereby maintaining systemic glucose homeostasis (StatPearls, 2023). In Type 1 diabetes, these cells are selectively destroyed by an autoimmune response, while in Type 2 diabetes, they become progressively dysfunctional and fail to compensate for peripheral insulin resistance (NIH, 2022). Therapeutic interventions often target specific molecular components within these cells, such as the sulfonylurea receptor or the glucagon-like peptide-1 receptor, to modulate insulin secretion and improve glycemic control (PubMed, 2021). Monitoring beta-cell function is critical in managing metabolic disorders, often utilizing biomarkers like C-peptide to assess endogenous insulin production (PubMed, 2022). These cells remain a major focus of research for regenerative medicine and cell-based therapies aimed at curing diabetes.

Other names

Beta-cell$eta$-cellIslet beta cellPancreatic beta cellB-cell (pancreatic)

Pharmacological agents modulate beta-cell activity by targeting specific membrane proteins, such as ATP-sensitive potassium (KATP) channels to trigger depolarization or GLP-1 receptors to increase intracellular cAMP, both of which enhance glucose-dependent insulin release (StatPearls, 2023).